Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Javelin reports results from phase III efficacy study of Dyloject in postsurgical pain

Dec. 15, 2008

ITI presents development update of ITI-111 for acute repetitive seizure in epilepsy

Dec. 15, 2008

Abstral receives marketing approval in Germany for breakthrough cancer pain

Dec. 12, 2008

Perampanel well tolerated in phase II study in patients with refractory partial seizures

Dec. 12, 2008

Olanzapine long-acting injection approved in Europe for schizophrenia

Dec. 12, 2008

Preliminary phase II data suggest APD-125 did not meet trial endpoints

Dec. 12, 2008

AcelRx reports results from phase II clinical study of sufentanil in postoperative pain

Dec. 12, 2008

Phosphagenics presents phase I clinical results for transdermal lidocaine

Dec. 12, 2008

Sosei reports positive results from two phase I trials of SD-118 for neuropathic pain

Dec. 11, 2008

New therapeutic agents for AD and other neurological disorders reported in recent patents

Dec. 11, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...